Article summary
This week's edition of Life Sciences weekly highlights includes news that the national EU Competent Authorities published a consensus statement on the state-of-play of transitioning to the medical devices regulatory framework (MDR and IVDR) and called for further urgent reform, the CMA launched a call for input on its proposal to review the purpose of the Assimilated Technology Transfer Block Exemption Regulation, Assimilated Regulation (EU) 316/2014 (Assimilated TTBER) and it published its decision to clear the acquisition by Thermo Fisher Scientific of Olink, the EMA released a draft addendum to a guideline on vaccine development for the inclusion of immunocompromised people in clinical trials and the ASA found several ads making unauthorised medicinal claims in relation to prostrate matters, among other news.
To continue reading this news article, as well as thousands of others like it, sign in with LexisNexis or register for a free trial
Access this content for free with a 7 day trial of LexisNexis and benefit from:
- Instant clarification on points of law
- Smart search
- Workflow tools
- 42 practice areas
Get your quote today and take step closer to being able to benefit from:
- Instant clarification on points of law
- Smart search
- Workflow tools
- 36 practice areas
Get a quote for Lexis+
* denotes a required field
CONTACT US
